MST3-IN-1 (TFA)

CAT: 0804-HY-175208A-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-175208A-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

MST3-IN-1 TFA (Compound LD-1) is a selective and orally active MST3 inhibitor, with an IC50 of 122.4 nM. MST3-IN-1 TFA shows antiproliferative activity against HepG2 cell. MST3-IN-1 TFA effectively induces Apoptosis in HepG2 cells, and halts the cell cycle at the G2/M transition. MST3-IN-1 TFA significantly suppressed tumor growth in HepG2 xenograft mice. MST3-IN-1 TFA can be used for the study of liver cancer[1].

UNSPSC

12352005

Target

Apoptosis; Bcl-2 Family; Caspase; Hippo (MST)

Related Pathways

Apoptosis; Stem Cell/Wnt

Field of Research

Cancer

Purity

99.38

Smiles

O=C(C1=CN(C2CC2)C3=CC(N4CCNCC4)=C(C=C3C1=O)F)NC5=NC6=C(S5)C=C(OC(F)(F)F)C=C6.OC(C(F)(F)F)=O

Molecular Formula

C27H22F7N5O5S

Molecular Weight

661.55

References & Citations

[1]Li D, et al. Design and synthesis of Riluzole-Ciprofloxacin hybrids as selective MST3 inhibitors for cancer treatment. Eur J Med Chem. 2025 Jun 28;297:117923.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Related Products

Catalog	Name
HY-175208	MST3-IN-1
HY-P1681A-01	GpTx-1 (TFA)
HY-19617B-01	EGFR-IN-1 (TFA)
HY-P3139A	TPP-1 (TFA)
HY-P1409A-01	ADWX 1 (TFA)
HY-173076A-01	HDAC11-IN-1 (TFA)
HY-P1411A-01	Psalmotoxin 1 (TFA)
HY-122641D-01	Deltasonamide 1 (TFA)
HY-P0269A-01	Magainin 1 (TFA)
HY-P1954A-01	Epinecidin-1 (TFA)

Alternative Products

Catalog	Name
GTR19274389-01	MST3-IN-1 TFA
GTR19213125	Aβ-IN-1 TFA
BUP21757	Aß-IN-1 TFA
LWD75992-01	SETD2-IN-1 TFA
T40251	DTAGV-1 TFA
T204739-01	TMPRSS6-IN-1 TFA
TP3667-01	Phlotoxin-1 TFA
T63447	FTO-IN-1 TFA
T64247-01	CREB-IN-1 TFA
T76198-01	TPP-1 TFA

MST3-IN-1 (TFA)

Related Products

Alternative Products

Popular Products